General Information of the Compound
| Compound ID |
CP0900316
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
4-Methyl-3,6-dihydro-1H-pyridin-(2Z)-ylideneamine
Show/Hide
|
||||||||||||||||||
| Synonyms |
4-Methyl-3,6-dihydro-1H-pyridin-(2Z)-ylideneamine
AKOS006358726
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C6H10N2
|
||||||||||||||||||
| Molecular Weight |
110.16
|
||||||||||||||||||
| Canonical SMILES |
CC1=CCN=C(N)C1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C6H10N2/c1-5-2-3-8-6(7)4-5/h2H,3-4H2,1H3,(H2,7,8)
Show/Hide
|
||||||||||||||||||
| InChIKey |
ZOKOWWYVKANQNJ-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01856, Nitric oxide synthase 3
Protein ID: PT01472, Nitric oxide synthase, inducible
Clinical Information about the Compound